Logo image
Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment
Journal article   Peer reviewed

Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment

M.J. Fabis-Pedrini, W. Xu, J. Burton, W.M. Carroll and A.G. Kermode
Journal of Clinical Neuroscience, Vol.25, pp.145-147
2016
url
Link to Published Version *Subscription may be requiredView

Abstract

We report a case of asymptomatic progressive multifocal leukoencephalopathy (PML) detected on regular MRI screening in a 40-year-old patient with subsequent benign course with 12 months follow-up. The patient had a history of aggressive inflammatory multiple sclerosis, prior mitoxantrone therapy, Stratify John Cunningham Virus test positivity (Quest Diagnostics, Madison, NJ, USA), and 5 years of natalizumab monotherapy. The initial MRI detection of PML was both atypical and subtle. Early diagnosis and intervention, and pre-emptive treatment for immune reconstitution inflammatory syndrome with high dose steroids, as well as empirical mirtazapine and mefloquine, were associated with a benign PML disease course and outcome.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.161 Virology - Identification & Sequencing
1.161.1385 Polyomavirus Oncogenesis
Web Of Science research areas
Clinical Neurology
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image